Webinar: Continuous Verification in Pharmaceutical Analysis
Thursday, 30 July 2020 14.00 - 15.30 h
Course No. 18040
Speakers
Dr. Joachim Ermer
Ermer Quality Consulting
Important: Deadline is 12 noon on 29 July 2020.
Background
According to the FDA-Guidance „Analytical procedures and methods validation for drugs and biologics“, it should be continually assured that an analytical procedure remains fit for its intended purpose throughout its application. This includes an ongoing program for routine monitoring of analytical performance data, and the systematic evaluation of changes with the objective to evaluate regularly the need for optimization and revalidation, if needed. These activities belong to stage 3 of the analytical lifecycle management as discussed in the draft of the new USP information chapter <1220>. The on-going performance verification is also intended to be included in the revision of the ICH validation guideline Q2.
Target Group
The webinar is aimed at executives and employees from Quality Control, Quality Assurance, and production who want to gain a better understanding of the GMP requirements as well as current discussions with respect to the lifecycle management of analytical procedures and are interested in practical recommendations for an efficient design, execution, and evaluation of a continuous analytical performance verification.
Technical Requirements
For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.
At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in. Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.
Programme
Besides regulatory expectations, the Webinar provides practical recommendations and orientation for demonstration of the on-going suitability of analytical procedures. In particular, efficient approaches will be presented to extract information and data from routine analysis. This will be illustrated with examples from quality control of chemical drug substances and bio-pharmaceuticals. A comprehensive understanding of the real analytical performance is extremely helpful to investigate and evaluate suspect or out-of specification (OOS) results as well as for a continuous process validation.
The following topics will be covered in the webinar:
Regulatory requirements
Integration into the analytical lifecycle concept (draft USP information chapter <1220>)
Benefits of monitoring analytical performance
What are the sources of analytical performance information?
Risk-based identification of suitable performance parameters (SST, from sample analysis, control samples)
Evaluation of information and data (OOS, invalid results, control charts, average parameters)
Testimonials